|
|
|
Hits Today: 0 |
Overall Hits : 0 |
Updated: 2/19/2007 |
Avg. Hit :0.0
|
|
Researches and develops proprietary emulsions for lipophilic drugs, including formulations for cancer treatment. Outlines phase II studies, presentation and profile of company in Bothell, Washington. (Nasdaq: SNUS) |
|
Write Your Own Review
|
